Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
Status:
Completed
Trial end date:
2016-12-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and
efficacy of JBT-101 in adult subjects with cystic fibrosis (CF).